Search Results 711-720 of 19177 for alzheimers
His research interests have focused primarily on improving the early detection of mild cognitive impairment (MCI) and dementia, such as Alzheimer's disease. He ...
T-cell receptor diversity may be key to treatment of follicular lymphoma, Mayo study. Cancer ; Research finds ethnoracial differences in Alzheimer's disease ...
PBS show shines spotlight on Alzheimer's disease featured image. Featured ... Immunotherapy: Testing a new treatment for Alzheimer's disease featured image.
... Alzheimer's disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
New NIH consortium to streamline clinical trials for Alzheimer's disease, related dementias. Susan Barber Lindquist. December 11, 2017. Research. Fetal Neural ...
The purpose of this study is to validate the Alzheimer Disease Biomarkers assays (Phospho-Tau/Total-Tau/Ab42) being implemented at Mayo to compare them to the ...
Mild cognitive impairment (MCI) is a transitional state between normal aging and the earliest features of Alzheimer's disease. It is a disorder of the brain ...
The purpose of this study is to evaluate the safety and effectiveness of MABT5102A in patients who have mild to moderate Alzheimer's Disease. Participation ...
Maria Vassilaki, M.D., Ph.D., is a Mayo Clinic epidemiologist focused on cognitive decline, mild cognitive impairment, and Alzheimer's disease and related ...
Developing and validating magnetic resonance imaging techniques for diagnosis and measuring progression of Alzheimer's disease and related disorders, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.